葛根素注射液联合丹参酮ⅡA磺酸钠治疗慢性充血性心力衰竭患者的疗效及对血浆血浆肾素活性和醛固酮的影响(4)
[12]伟唯，江培.葛根素药理作用研究进展[J].黑龙江医药，2014，27(1)：1021-1023，1024.
[13]Roth S，Fox H，Fuchs U，et al.Noninvasive pulse contour analysis for determination of cardiac output in patients with chronic heart failure[J].Clin Res Cardiol，2018，107(5)：395-404.
[14]Romagnoli S，Zagli G，Ricci Z，et al.Cardiac output：a central issue in patients with respiratory extracorporeal support[J].Perfusion，2017，32(1)：44-49.
[15]Assmus B，Walter DH，Seeger FH，et al.Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure：the CELLWAVE randomized clinical trial[J].JAMA，2013，309(15)：1622-1631.
[16]許耀，徐晗，郝云霞，等.前列地尔对慢性充血性心力衰竭患者心功能及预后的影响[J].中国循证心血管医学杂志，2016，8(7)：823-826，832.
[17]Nijst P，Verbrugge FH，Martens P，et al.Plasma renin activity in patients with heart failure and reduced ejection fraction on optimal medical therapy[J].J Renin Angiotensin Aldosterone Syst，2017，18(3)：1470320317729919.
[18]Schroeder EB，Chonchol M，Shetterly SM，et al.Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes：A Comparative Effectiveness Study[J].Clin J Am Soc Nephrol，2018，13(5)：727-734.
[19]Tamargo J，Caballero R，Delpón E.New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors[J].Cardiovasc Drugs Ther，2018，32(1)：99-119.
(2018-08-23收稿 责任编辑：杨觉雄), http://www.100md.com(曾胜煌 何长国 王越)
[13]Roth S，Fox H，Fuchs U，et al.Noninvasive pulse contour analysis for determination of cardiac output in patients with chronic heart failure[J].Clin Res Cardiol，2018，107(5)：395-404.
[14]Romagnoli S，Zagli G，Ricci Z，et al.Cardiac output：a central issue in patients with respiratory extracorporeal support[J].Perfusion，2017，32(1)：44-49.
[15]Assmus B，Walter DH，Seeger FH，et al.Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure：the CELLWAVE randomized clinical trial[J].JAMA，2013，309(15)：1622-1631.
[16]許耀，徐晗，郝云霞，等.前列地尔对慢性充血性心力衰竭患者心功能及预后的影响[J].中国循证心血管医学杂志，2016，8(7)：823-826，832.
[17]Nijst P，Verbrugge FH，Martens P，et al.Plasma renin activity in patients with heart failure and reduced ejection fraction on optimal medical therapy[J].J Renin Angiotensin Aldosterone Syst，2017，18(3)：1470320317729919.
[18]Schroeder EB，Chonchol M，Shetterly SM，et al.Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes：A Comparative Effectiveness Study[J].Clin J Am Soc Nephrol，2018，13(5)：727-734.
[19]Tamargo J，Caballero R，Delpón E.New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors[J].Cardiovasc Drugs Ther，2018，32(1)：99-119.
(2018-08-23收稿 责任编辑：杨觉雄), http://www.100md.com(曾胜煌 何长国 王越)